IDEXX Laboratories Hits Day High with Strong 3.39% Intraday Surge

IDEXX Laboratories, Inc. has shown significant activity today, with the stock rising by 3.39% on April 17, 2026. The stock reached an intraday high of USD 594.11, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. Over the past year, IDEXX has outperformed the S&P 500, generating a return of 32.13% compared to the index's 11.87%. The company's robust financial metrics include a high return on capital employed (ROCE) of 54.00%, indicating effective management efficiency. Additionally, IDEXX maintains a low debt to EBITDA ratio of 0.75 times, showcasing its strong ability to service debt. In terms of growth, IDEXX has demonstrated healthy long-term prospects, with operating profit increasing at an annual rate of 14.53%. The stock's price-to-earnings (P/E) ratio stands at 56.00, and it has a price-to-book ratio of 37.09. With institutional holdings at 96.26%, IDEXX Laboratories continues to maintain a solid market position, reflecting confidence from large investors.